Welcome
Support Centre
21 March 2013 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes
statistics

[ Print-friendly version ]
Clinical trial to compare electrical stimulation and the conventional ankle-foot orthosis (AFO) in the treatment of dropped foot following stroke
ISRCTN ISRCTN72463123
DOI 10.1186/ISRCTN72463123
ClinicalTrials.gov identifier
EudraCT number
Public title Clinical trial to compare electrical stimulation and the conventional ankle-foot orthosis (AFO) in the treatment of dropped foot following stroke
Scientific title
Acronym N/A
Serial number at source AP0770
Study hypothesis To compare functional electrical stimulation (FES) with ankle foot orthosis (AFO) in the treatment of dropped foot following stroke. The conventional AFO is cheaper, easier to apply than FES and provides consistent and stable support. However, FES allows more passive and active movement of the ankle than the conventional AFO.
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Foot drop
Participants - inclusion criteria 1. Single stroke of vascular origin in the last 6 months
2. Inadequate dorsiflexion during the swing phase of gait
3. May be a candidate for ankle-foot orthosis (AFO)
4. Able to walk 10 m
5. Willing to participate
Participants - exclusion criteria 1. Previous use of a dropped foot stimulator or AFO in four weeks prior to start of intervention
2. Required an AFO other than that selected for the trial
Anticipated start date 01/01/1998
Anticipated end date 31/12/2000
Status of trial Completed
Patient information material
Target number of participants 22
Interventions 1. One group treated with AFO
2. Second group with electrical stimulation
Primary outcome measure(s) 1. Walking speed (measured over 10 metres and timed by a stopwatch)
2. Physiological Cost Index (PCI)
3. Endurance (the total distance the participant is able to walk without an AFO or FES in 3 minutes)
4. Calf spasticity (measured using the modified Ashworth Scale)
5. Mobility (measured using the Rivermead Mobility Index)

Outcome measures were taken every six weeks.
Secondary outcome measure(s) Not provided at time of registration
Sources of funding Action Medical Research (UK)
Trial website
Publications
Contact name Dr  Philip  Wright
  Address Department of Medical Physics and Biomedical Engineering
Salisbury District Hospital
  City/town Salisbury
  Zip/Postcode SP2 8BJ
  Country United Kingdom
  Tel +44 (0)1722 336 262 ext 4686
  Email p.wright@salisburyfes.com
Sponsor Action Medical Research (UK)
  Address Vincent House
  City/town Horsham West Sussex
  Zip/Postcode RH12 2DP
  Country United Kingdom
  Tel +44 (0)1403 210 406
  Fax +44 (0)1403 210 541
  Email info@actionresearch.co.uk
  Sponsor website: http://www.action.org.uk/
Date applied 01/03/2001
Last edited 04/11/2010
Date ISRCTN assigned 01/03/2001
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2013 ISRCTN unless otherwise stated.